Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 12;66(2):257-262.
doi: 10.33160/yam.2023.05.016. eCollection 2023 May.

The Clinical Characteristics of Allergic Bronchopulmonary Mycosis Differ Among Pathogenic Fungi

Tomoya Harada  1 , Genki Inui  1 , Hiroki Ishikawa  1 , Ryohei Kato  1 , Yuriko Sueda  1 , Yoshihiro Funaki  1 , Miki Takata  1 , Ryota Okazaki  1 , Masato Morita  1 , Shin Kitatani  2 , Akira Yamasaki  1
Affiliations

The Clinical Characteristics of Allergic Bronchopulmonary Mycosis Differ Among Pathogenic Fungi

Tomoya Harada et al. Yonago Acta Med. .

Abstract

Background: Allergic bronchopulmonary mycosis (ABPM) occurs with fungi, other than Aspergillus fumigatus. However, the clinical characteristics of ABPM caused by non-Aspergillus species are unspecified.

Methods: We retrospectively reviewed all patients with ABPM who visited to our hospital between April 2005 and December 2020. The causative fungi and clinical characteristics were analyzed. Patients were divided into the Aspergillus group and the non-Aspergillus group.

Results: Fourteen patients and five patients were included in the Aspergillus group and the non-Aspergillus group, respectively. Compared to the Aspergillus group, the non-Aspergillus group had a significantly low serum immunoglobulin E level and low forced vital capacity. In addition, the non-Aspergillus group had a lower rate of the requirement for oral corticosteroid treatment and a low frequency of recurrence.

Conclusion: Patients with non-Aspergillus ABPM had lower type 2 inflammation than did patients with allergic bronchopulmonary aspergillosis.

Keywords: allergic bronchopulmonary aspergillosis; allergic bronchopulmonary mycosis; characteristics; fungus; recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

References

    1. Hinson KFW,Moon AJ,Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952;7:317-33. 10.1136/thx.7.4.317 - DOI - PMC - PubMed
    1. Knutsen AP,Bush RK,Demain JG,Denning DW,Dixit A,Fairs A,et al. . Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol. 2012;129:280-91. 10.1016/j.jaci.2011.12.970 - DOI - PubMed
    1. Agarwal R,Chakrabarti A,Shah A,Gupta D,Meis JF,Guleria R,et al. ; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850-73. 10.1111/cea.12141 - DOI - PubMed
    1. Chowdhary A,Agarwal K,Kathuria S,Gaur SN,Randhawa HS,Meis JF. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus : a global overview. Crit Rev Microbiol. 2014;40:30-48. 10.3109/1040841X.2012.754401 - DOI - PubMed
    1. Rosenberg M,Patterson R,Mintzer R,Cooper BJ,Roberts M,Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977;86:405-14. 10.7326/0003-4819-86-4-405 - DOI - PubMed